Drug · DIN 00548375
CESAMET
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since May 27, 2019; first marketed December 31, 1982.
- Drug Identification Number (DIN)
- 00548375
- Company (DIN owner)
- Bausch Health, Canada Inc.Laval, Quebec, Canada
- Schedule
- Narcotics (cdsa ii)
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Nabilone A04AD11
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| NABILONE | 1 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- May 27, 2019: NOC 22200New Drug Submission (NDS) · Administrative: Change in Product Ownership
- September 21, 2004: NOC 5415New Drug Submission (NDS) · Manufacturer name change
- April 20, 2000: NOC 1349New Drug Submission (NDS)
Other DINs named CESAMET
- DIN 02256193 · Marketed
- DIN 02312263 · Marketed